Assyro AI

Orange Book product · Brand (NDA)

VENLAFAXINE BESYLATE

VENLAFAXINE BESYLATE

Brand (NDA)NDA 215429RX ALMATICA

At a glance

Jun 29, 2022

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 29, 2022

    4 yr ago

  2. Today

  3. Patent 7776358 expires

    Listed drug product patent expiration.

    May 16, 2028

    in 1 yr 11 mo

Pharmaceutical detail

Active ingredient

VENLAFAXINE BESYLATE

Strength

EQ 112.5MG BASE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 215429

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7776358May 16, 2028in 1 yr 11 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.